Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma

Abstract Background Autologous stem cell transplantation (ASCT) is the standard treatment strategy for refractory or relapsed classical Hodgkin lymphoma (R/R cHL). However, a single transplantation is insufficient to cure the disease because of unfavorable risk factors. Herein, we evaluated the outc...

Full description

Bibliographic Details

Published in:	Cancer Medicine
Main Authors:	Chen Zhang, Jili Deng, Yan Xie, Lan Mi, Weiping Liu, Xiaopei Wang, Linjun Zhao, Yuqin Song, Jun Zhu
Format:	Article
Language:	English
Published:	Wiley 2023-05-01
Subjects:	refractory or relapsed classical Hodgkin lymphoma single autologous stem cell transplantation tandem autologous stem cell transplantation unfavorable risk
Online Access:	https://doi.org/10.1002/cam4.5765